trending Market Intelligence /marketintelligence/en/news-insights/trending/a15LekC9CPqK0Flo6aK6zQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

DBV Technologies chief medical officer resigns; interim named

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


DBV Technologies chief medical officer resigns; interim named

DBV Technologies S.A. said Lucia Septien-Velez is leaving her role as the company's chief medical officer to pursue other opportunities.

Hugh Sampson, DBV's chief scientific officer since June 2015, will now also serve as interim chief medical officer.

Paris-based DBV Technologies is developing a proprietary technology platform for use in immunotherapy.